Aller au contenu principal
Profil bibliographique

Y Kubota

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

2Publications signalées
0Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Heart Failure Treatment and ManagementNutrition and Health in AgingDiabetes Treatment and ManagementCardiovascular Function and Risk FactorsFrailty in Older Adults

Les publications récentes

2025 article OpenAlex

Worsening renal function in acute heart failure: the impact on subsequent kidney function and its association with haemoconcentration

Y Watanabe, Y Kubota, T Nishino, S Tara et autres

Abstract Background Worsening renal function (WRF) in acute heart failure (AHF) has traditionally been associated with poor outcomes. However, when adequate decongestion is achieved with haemoconcentration, it does not necessarily lead to adverse outcomes. Nevertheless, its impact on kidney disease progression remains …

jp (code pays fourni par la source)

0 citations European Heart Journal
2025 article OpenAlex

Impact of sarcopenia and osteopenia on prognosis in elderly heart failure patients: a computed tomography-based comparative study

S Asami, Y Kubota, Y Watanabe, T Nishino et autres

Abstract Background Frailty, including sarcopenia and osteopenia, is an independent prognostic determinant in patients with heart failure (HF). However, the evaluation of sarcopenia or osteopenia requires measurement of grip strength, walking speed, skeletal muscle mass and bone density test. Frailty is a …

jp (code pays fourni par la source)

0 citations European Heart Journal
2025 article OpenAlex

Phenotypes of heart failure with preserved ejection fraction and effect of sodium-glucose cotransporter 2 inhibitors treatment

A Sezaki, Y Kubota, T Nishino, Y Watanabe et autres

Abstract Background Phenotypic heterogeneity of heart failure with preserved ejection fraction (HFpEF) has been reported, particularly among racial groups. While phenotype-specific treatment for HFpEF has attracted attention, the effectiveness of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in this context remains uncertain. Aims This …

jp (code pays fourni par la source)

0 citations European Heart Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.